CHANDLER, Ariz. — For someone who was looking to take a little bit of a step back from competition, Lexi Thompson is still a strong competitor. The 11-time LPGA winner said before the 2025 season that ...

Amid the disappointment, the Sabres have a lone bright spot. Forward Tage Thompson continues to be an offensive gift to Buffalo, giving the team a goal scorer unlike any they've had before.

Sanofi SNY announced that the FDA has accepted its regulatory filing seeking approval for its investigational BTK inhibitor tolebrutinib to treat non-relapsing secondary progressive multiple ...

The loved ones of 22-month-old Ebony Thompson began to weep as her mother ... Under cross examination from the child care centre’s barrister Adam Mason, Mr Wheeler confirmed Ms Kaur had not ...

Jul 10 2024 Brief of respondent United States in opposition filed. Jul 17 2024 Reply of petitioner Patrick D. Thompson filed. Jul 24 2024 DISTRIBUTED for Conference of 9/30/2024. Oct 04 2024 Petition ...

Paris: Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire DR-0201, a targeted bispecific ...

Sanofi (NASDAQ:SNY) has agreed to acquire an immunology drug from clinical-stage biopharmaceutical company Dren Bio for up to $1.9B. The French pharmaceutical company will acquire DR-0201, a CD20 ...

Sanofi SNY announced that it signed an agreement with California-based privately held biopharmaceutical company Dren Bio to acquire the latter’s investigational bispecific antibody DR-0201.

PARIS, France I March 20, 2025 I Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire ...

Sanofi (NASDAQ:SNY) has struck a major deal to acquire Dren Bio’s autoimmune disease treatment, DR-0201, reinforcing its expansion in the biopharmaceutical sector. The French healthcare giant ...

Sanofi said it would acquire Bispecific Myeloid Cell Engager, an autoimmune disease treatment, from Dren Bio, for up to $1.9 billion. The French pharmaceutical company on Thursday said it would ...

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...